The contract development and manufacturing organization (CDMO) Ardena, has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients. The acquisition, which is the CDMO’s first outside the Benelux region, expands its drug substance manufacturing capacity and means that bigger batch sizes up to 100 kg can now be handled by Ardena. Syntagon also adds specialist expertise in GMP chromatographic purification processes to the group. The an...